Advertisement

Rheumatology International

, Volume 33, Issue 8, pp 1991–1999 | Cite as

The PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis

  • Gwan Gyu Song
  • Sang-Cheol Bae
  • Jae-Hoon Kim
  • Young Ho LeeEmail author
Original Article

Abstract

The aim of this study was to determine whether the protein tyrosine phosphatase nonreceptor 22 (PTPN22) C1858T polymorphism confers susceptibility to rheumatoid arthritis (RA) in populations with different ethnicities. MEDLINE database and manual search were utilized to identify articles in which the PTPN22 polymorphism was determined in RA patients and controls. A meta-analysis was conducted on the associations between the PTPN22 C1858T polymorphism and RA using (1) allelic contrast and (2) dominant model. A total of 30 separate comparisons involving 17,961 RA patients and 18,611 controls were considered in this meta-analysis. Meta-analysis showed an association between the T allele and RA in all subjects (OR = 1.490, 95 % CI = 1.332–1.668, P < 1.0 × 10−9). After stratification by ethnicity, analysis indicated that the T allele was significantly associated with RA in Europeans and in Non-Europeans (OR = 1.423, 95 % CI = 1.260–1.605, P = 1.0 × 10−8; OR = 1.902, 95 % CI = 1.488–2.430, P = 2.8 × 10−8). Meta-analysis of the CT + TT genotype showed the same result patterns as that shown by the PTPN22 C1858T polymorphism T allele. Furthermore, a direct comparison between rheumatoid factor (RF)-positive and RF-negative subjects revealed a significant association with the T allele in RA patients with RF, but not in subjects without RF (OR = 1.561, 95 % CI = 1.373–1.775, P < 1.0 × 10−9). This meta-analysis confirms that the PTPN22 C1858T polymorphism is associated with RA susceptibility in different ethnic groups, especially in Europeans, and the PTPN22 C1858T polymorphism T allele is significantly more prevalent in RF-positive patents than in RF-negative patients.

Keywords

Protein tyrosine phosphatase nonreceptor 22 Polymorphism Rheumatoid arthritis Meta-analysis 

Notes

Acknowledgments

This study is supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065).

Conflict of interest

We have no financial and nonfinancial conflicts of interest.

Supplementary material

296_2013_2679_MOESM1_ESM.doc (40 kb)
Supplementary material 1 (DOC 39 kb)
296_2013_2679_MOESM2_ESM.doc (74 kb)
Supplementary material 2 (DOC 73 kb)

References

  1. 1.
    MacGregor AJ, Snieder H, Rigby AS et al (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43(1):30–37PubMedCrossRefGoogle Scholar
  2. 2.
    Kim HR, Park MK, Cho ML et al (2010) Induction of macrophage migration inhibitory factor in ConA-stimulated rheumatoid arthritis synovial fibroblasts through the P38 map kinase-dependent signaling pathway. Korean J Intern Med 25(3):317–326PubMedCrossRefGoogle Scholar
  3. 3.
    Choi SJ, Rho YH, Ji JD, Song GG, Lee YH (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology 45(2):166–170PubMedCrossRefGoogle Scholar
  4. 4.
    Siminovitch KA (2004) PTPN22 and autoimmune disease. Nat Genet 36(12):1248–1249PubMedCrossRefGoogle Scholar
  5. 5.
    Gregersen PK (2005) Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond. Immunol Rev 204:74–86PubMedCrossRefGoogle Scholar
  6. 6.
    Cohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM (1999) Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93(6):2013–2024PubMedGoogle Scholar
  7. 7.
    Bottini N, Musumeci L, Alonso A et al (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36(4):337–338PubMedCrossRefGoogle Scholar
  8. 8.
    Begovich AB, Carlton VE, Honigberg LA et al (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75(2):330–337PubMedCrossRefGoogle Scholar
  9. 9.
    Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC (2004) PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 303(5658):685–689PubMedCrossRefGoogle Scholar
  10. 10.
    Torres-Carrillo NM, Ruiz-Noa Y, Martinez-Bonilla GE et al (2012) The +1858C/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western Mexico. Immunol Lett 147(1–2):41–46PubMedCrossRefGoogle Scholar
  11. 11.
    Mihailova A, Mikazane H, Klovins J, Nikitina-Zake L (2011) Association of protein tyrosine phosphatase non-receptor 22 (PTPN22) rs2476601 and Kruppel-like factor 12 (KLF12) rs1324913 single nucleotide polymorphisms with rheumatoid arthritis in a Latvian population. Scand J Rheumatol 40(6):491–492PubMedCrossRefGoogle Scholar
  12. 12.
    Totaro MC, Tolusso B, Napolioni V et al (2011) PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case–control study and meta-analysis. PLoS ONE 6(9):e24292PubMedCrossRefGoogle Scholar
  13. 13.
    El-Gabalawy HS, Robinson DB, Daha NA et al (2011) Non-HLA genes modulate the risk of rheumatoid arthritis associated with HLA-DRB1 in a susceptible North American Native population. Genes Immun 12(7):568–574PubMedCrossRefGoogle Scholar
  14. 14.
    Ates A, Karaaslan Y, Karatayli E et al (2011) Association of the PTPN22 gene polymorphism with autoantibody positivity in Turkish rheumatoid arthritis patients. Tissue Antigens 78(1):56–59PubMedCrossRefGoogle Scholar
  15. 15.
    Rodriguez-Rodriguez L, Taib WR, Topless R et al (2011) The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case–control samples. Arthritis Rheum 63(2):365–372PubMedCrossRefGoogle Scholar
  16. 16.
    Eliopoulos E, Zervou MI, Andreou A et al (2011) Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete. Lupus 20(5):501–506PubMedCrossRefGoogle Scholar
  17. 17.
    Majorczyk E, Pawlik A, Kusnierczyk P (2010) PTPN22 1858C>T polymorphism is strongly associated with rheumatoid arthritis but not with a response to methotrexate therapy. Int Immunopharmacol 10(12):1626–1629PubMedCrossRefGoogle Scholar
  18. 18.
    Stark K, Rovensky J, Blazickova S et al (2009) Association of common polymorphisms in known susceptibility genes with rheumatoid arthritis in a Slovak population using osteoarthritis patients as controls. Arthritis Res Ther 11(3):R70PubMedCrossRefGoogle Scholar
  19. 19.
    Mastana S, Gilmour A, Ghelani A, Smith H, Samanta A (2007) Association of PTPN22 with rheumatoid arthritis among South Asians in the UK. J Rheumatol 34(10):1984–1986PubMedGoogle Scholar
  20. 20.
    Viken MK, Olsson M, Flam ST et al (2007) The PTPN22 promoter polymorphism −1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material. Tissue Antigens 70(3):190–197PubMedCrossRefGoogle Scholar
  21. 21.
    Kokkonen H, Johansson M, Innala L, Jidell E, Rantapaa-Dahlqvist S (2007) The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther 9(3):R56PubMedCrossRefGoogle Scholar
  22. 22.
    Harrison P, Pointon JJ, Farrar C, Brown MA, Wordsworth BP (2006) Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients. Rheumatology 45(8):1009–1011PubMedCrossRefGoogle Scholar
  23. 23.
    Hinks A, Barton A, John S et al (2005) Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 52(6):1694–1699PubMedCrossRefGoogle Scholar
  24. 24.
    Simkins HM, Merriman ME, Highton J et al (2005) Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. Arthritis Rheum 52(7):2222–2225PubMedCrossRefGoogle Scholar
  25. 25.
    Orozco G, Sanchez E, Gonzalez-Gay MA et al (2005) Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 52(1):219–224PubMedCrossRefGoogle Scholar
  26. 26.
    Seldin MF, Shigeta R, Laiho K et al (2005) Finnish case–control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun 6(8):720–722PubMedGoogle Scholar
  27. 27.
    Wesoly J, van der Helm-van Mil AH, Toes RE et al (2005) Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort. Arthritis Rheum 52(9):2948–2950PubMedCrossRefGoogle Scholar
  28. 28.
    Steer S, Lad B, Grumley JA, Kingsley GH, Fisher SA (2005) Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset/disease severity effect. Arthritis Rheum 52(1):358–360PubMedCrossRefGoogle Scholar
  29. 29.
    Gomez LM, Anaya JM, Gonzalez CI et al (2005) PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun 6(7):628–631PubMedCrossRefGoogle Scholar
  30. 30.
    Zhernakova A, Eerligh P, Wijmenga C, Barrera P, Roep BO, Koeleman BP (2005) Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population. Genes Immun 6(6):459–461PubMedCrossRefGoogle Scholar
  31. 31.
    van Oene M, Wintle RF, Liu X et al (2005) Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn’s disease, in Canadian populations. Arthritis Rheum 52(7):1993–1998PubMedCrossRefGoogle Scholar
  32. 32.
    Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2006) Association of TNF-alpha −308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int 27(2):157–161PubMedCrossRefGoogle Scholar
  33. 33.
    Nath SK, Harley JB, Lee YH (2005) Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 118(2):225–234PubMedCrossRefGoogle Scholar
  34. 34.
    Lee YH, Witte T, Momot T et al (2005) The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case–control studies and a meta-analysis. Arthritis Rheum 52(12):3966–3974PubMedCrossRefGoogle Scholar
  35. 35.
    Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558PubMedCrossRefGoogle Scholar
  36. 36.
    Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315(7121):1533–1537PubMedCrossRefGoogle Scholar
  37. 37.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188PubMedCrossRefGoogle Scholar
  38. 38.
    Clark MF, Baudouin SV (2006) A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med 32(11):1706–1712PubMedCrossRefGoogle Scholar
  39. 39.
    Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634PubMedCrossRefGoogle Scholar
  40. 40.
    Chabchoub G, Teixiera EP, Maalej A et al (2009) The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Ann Hum Biol 36(3):342–349PubMedCrossRefGoogle Scholar
  41. 41.
    Lie BA, Viken MK, Odegard S et al (2007) Associations between the PTPN22 1858C → T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 66(12):1604–1609PubMedCrossRefGoogle Scholar
  42. 42.
    Martin JE, Alizadeh BZ, Gonzalez-Gay MA et al (2011) Evidence for PTPN22 R620W polymorphism as the sole common risk variant for rheumatoid arthritis in the 1p13.2 region. J Rheumatol 38(11):2290–2296PubMedCrossRefGoogle Scholar
  43. 43.
    Plant D, Flynn E, Mbarek H et al (2010) Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis 69(8):1548–1553PubMedCrossRefGoogle Scholar
  44. 44.
    Sahin N, Gunduz F, Inanc N, Direskeneli H, Saruhan-Direskeneli G (2009) No association of PTPN22 gene polymorphism with rheumatoid arthritis in Turkey. Rheumatol Int 30(1):81–83PubMedCrossRefGoogle Scholar
  45. 45.
    Zhebrun D, Kudryashova Y, Babenko A et al (2011) Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves’ disease but not with rheumatoid arthritis in Russian population. Aging 3(4):368–373PubMedGoogle Scholar
  46. 46.
    Farago B, Talian GC, Komlosi K et al (2009) Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects. Rheumatol Int 29(7):793–796PubMedCrossRefGoogle Scholar
  47. 47.
    Lee YH, Rho YH, Choi SJ et al (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis. Rheumatology (Oxford) 46(1):49–56CrossRefGoogle Scholar
  48. 48.
    Gregersen PK, Lee HS, Batliwalla F, Begovich AB (2006) PTPN22: setting thresholds for autoimmunity. Semin Immunol 18(4):214–223PubMedCrossRefGoogle Scholar
  49. 49.
    Lee HS, Korman BD, Le JM et al (2009) Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. Arthritis Rheum 60(2):364–371PubMedCrossRefGoogle Scholar
  50. 50.
    Ban Y, Tozaki T, Taniyama M, Tomita M (2005) The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid 15(10):1115–1118PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Gwan Gyu Song
    • 1
  • Sang-Cheol Bae
    • 2
  • Jae-Hoon Kim
    • 1
  • Young Ho Lee
    • 1
    Email author
  1. 1.Division of Rheumatology, Department of Internal Medicine, Korea University Anam HospitalKorea University College of MedicineSeoulKorea
  2. 2.The Hospital for Rheumatic DiseasesHanyang University Medical CenterSeoulKorea

Personalised recommendations